✦ LIBER ✦

EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

✍ Scribed by Sitbon, Olivier; Delcroix, Marion; Bergot, Emmanuel; Boonstra, Anco B.; Granton, John; Langleben, David; Subías, Pilar Escribano; Galiè, Nazzareno; Pfister, Thomas; Lemarié, Jean-Christophe; Simonneau, Gérald

Book ID: 122332125
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 490 KB
Volume: 167
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2013.08.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two formulations of epoprostenol sodium

Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study

✍ Chin, Kelly M.; Badesch, David B.; Robbins, Ivan M.; Tapson, Victor F.; Palevsky 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 603 KB

Erratum to: Evaluation of a New Formulat

Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)

✍ Yuichi Tamura, Tomohiko Ono, Keiichi Fukuda, Toru Satoh… 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 310 KB

A Multicenter Open-Label Study to Assess

A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer

✍ Charles Butts; R. Nevin Murray; Colum J. Smith; Peter M. Ellis; Kevin Jasas; And 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB